Source | Match | ReputationScore* |
---|---|---|
MATCH
2000 health care workers in NHS Tayside and from social care will have blood samples tested to detect antibodies to SARS-CoV-2, to identify undiagnosed asymptomatic healthcare worker infections with COVID-19.
|
|
|
Sars-CoV-2 Immunity & REinfection EvaluatioN (SIREN)
Large-scale study testing blood samples and swabs obtained from healthcare workers who work in a clinical setting to see if infection with COVID-19 protects them from future episodes of infection.
|
|
|
COVID-19 Staff Testing of Antibody Responses Study (Co-STARS)
The cohort contains repeated serological antibody testing of at least 1000 healthcare workers at Great Ormond Street Hospital. Within this cohort, a subset of 150-250 staff members with confirmed (PCR positive) SARS-CoV-2 disease will be followed wit
...
|
|
|
Oxford Healthcare Workers
Oxford University Hospitals NHS Foundation Trust (OUH) offers both symptomatic and asymptomatic SARS-CoV-2 testing programmes to staff at its four teaching hospitals in Oxfordshire, UK. OUH offers both symptomatic and asymptomatic SARS-CoV-2 staff te
...
|
|
|
VIVALDI 2
UCL researchers have set up a national research study called “Vivaldi” with Four Seasons healthcare and the Department of Health and Social Care. The aim is to find out how many care home staff and residents have have have been infected with COVID-19
...
|
|
|
PANTHER study
The PANTHER study aims to deepen the understanding of susceptibility to, immunity from and transmission of Sars-Cov2 (the virus that causes Covid-19) in an at risk population. The PANTHER (PANdemic Tracking of Healthcare woRkers) study, is hosted at
...
|
|
|
COVIDsortium
The COVIDsortium study aims to identify host and pathogen correlates of protection and pathogenesis in SARS-CoV-2 infection. The prospective observational cohort study (n=1000) healthcare workers (HCWs) with serial data/sample collection pre & post C
...
|
|
|
REal-time Assessment of Community Transmission (REACT-2)
REal-time Assessment of Community Transmission (REACT-2) started in May 2020 to determine the prevalence of and trends in antibodies levels in study participants. This study involves approximately 150,000 unique people. REal-time Assessment of Commun
...
|
|
|
TRACK-COVID
SARS-CoV-2 virus stimulates a rapid antibody response in people with symptomatic and asymptomatic infection. Seroprevalence of SARS-CoV-2 antibodies in a population can serve as a useful measure of exposure and spread. Severe acute respiratory syndro
...
|
|
*ReputationScore indicates how established a given datasource is. Find out more.